Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Mar 14;11(10):1540-3.
doi: 10.3748/wjg.v11.i10.1540.

A blind, randomized comparison of racecadotril and loperamide for stopping acute diarrhea in adults

Hwang-Huei Wang  1 , Ming-Jium Shieh, Kuan-Fu Liao
Affiliations
Clinical Trial

A blind, randomized comparison of racecadotril and loperamide for stopping acute diarrhea in adults

Hwang-Huei Wang et al. World J Gastroenterol. .

Abstract

Aim: Racecadotril is a specific enkephalinase inhibitor that exhibits intestinal antisecretory activity without affecting intestinal transit. Loperamide is an effective anti-diarrheal agent, but it usually induces constipation. This study is to compare the efficacy, safety, and tolerability of racecadotril versus loperamide in the outpatient treatment of acute diarrhea in adults.

Methods: A two-center, randomized, parallel-group, single-blind study was carried out to compare the efficacy, tolerability, and safety of racecadotril (100 mg thrice daily) and loperamide (2.0 mg 2 twice daily) in 62 adult patients suffering from acute diarrhea. The main efficacy criterion used was the duration of diarrhea after beginning the treatment (in hours). Other signs and symptoms were also evaluated.

Results: The clinical success rates for these anti-diarrheal treatments were 95.7% and 92.0% for racecadotril and loperamide respectively. Patients on racecadotril had a median duration of diarrhea of 19.5 h compared with a median of 13 h for patients on loperamide. Rapid improvement in anal burn and nausea was found for each drug. However, more patients on loperamide suffered from reactive constipation (29.0% vs 12.9%). Itching, another adverse event was notably higher in the racecadotril group (28.6% vs 0%). With regard to other adverse events, the two medications showed similar occurrence rates and similar concomitant medication usage rates.

Conclusion: Racecadotril and loperamide are rapid, equally effective treatments for acute diarrhea in adults, but loperamide treatment is associated with a higher incidence of treatment-related constipation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean duration of diarrhea (h). ITT (intent-to-treat); PP (per protocol).
See this image and copyright information in PMC

References

    1. Sheeby TW. Digestive disease as a national problem. VI. Enteric disease among United States troops in Vietnam. Gastroenterology. 1968;55:105–112. - PubMed
    1. Sprinz H. Pathogenesis of intestinal infections. Arch Pathol. 1969;87:556–562. - PubMed
    1. Edelman R. Prevention and treatment of infectious diarrhea. Speculations on the next 10 years. Am J Med. 1985;78:99–106. - PubMed
    1. Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Mechanism of the antidiarrheal effect of loperamide. Gastroenterology. 1984;86:1475–1480. - PubMed
    1. Pollard H, Moreau J, Ronco P, Verroust P, Schwartz JC. Immunoautoradiographic localisation of enkephalinase (EC 3.4.24.11) in rat gastrointestinal tract. Neuropeptides. 1991;19:169–178. - PubMed